Activation_NN
of_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
enhancer_NN
is_VBZ
not_RB
dependent_JJ
on_IN
NFAT-1_NN
._.

The_DT
function_NN
of_IN
a_DT
putative_JJ
NFAT-1_NN
site_NN
in_IN
the_DT
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
enhancer_NN
has_VBZ
been_VBN
analyzed_VBN
._.

Activation_NN
by_IN
the_DT
T-cell_NN
antigen_NN
receptor_NN
is_VBZ
minimal_JJ
in_IN
Jurkat_NN
cells_NNS
and_CC
is_VBZ
mediated_VBN
by_IN
the_DT
kappa_NN
B_NN
sites_NNS
._.

The_DT
putative_JJ
NFAT-1_NN
region_NN
is_VBZ
not_RB
required_VBN
for_IN
the_DT
response_NN
to_TO
anti-CD3_NN
or_CC
to_TO
mitogens_NNS
in_IN
T-cell_NN
,_,
B-cell_NN
,_,
or_CC
monocyte\/macrophage_JJ
leukemia_NN
lines_NNS
,_,
nor_CC
is_VBZ
it_PRP
a_DT
cis-acting_JJ
negative_JJ
regulatory_JJ
element_NN
._.

